Full name
MNM DIAGNOSTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W UPADŁOŚCI
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
58 - Publishing activities
61 - Telecommunications
62 - Activities related to programming, IT consulting, and related activities
63 - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70 - Head office activities and management consultancy
72 - Scientific research and development activities
86 - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -2,2 | -1,6 | -0,7 | 52,3 |
EBITDA | -2 | -1,3 | -0,4 | 69,4 |
Short time liabilities | 0,8 | 2,9 | 3 | 4,3 |
Equity capital | 0,2 | -1,3 | -2,1 | -55,8 |
Operating profit (EBIT) | -2,2 | -1,4 | -0,5 | 66,5 |
Assets | 3,4 | 1,5 | 1,3 | -13,1 |
Net profit (loss) | -2,2 | -1,6 | -0,7 | 52,3 |
Cash | 3,1 | 1,2 | 0,5 | -57,8 |
Net income from sale | 1,8 | 7 | 6 | -14,8 |
Liabilities and provisions for liabilities | 3,1 | 2,9 | 3,4 | 19,1 |
Working assets | 3,2 | 1,4 | 0,7 | -47,5 |
Depreciation | 0,1 | 0,1 | 0,1 | -23,6 |
% | % | % | p.p. | |
Profitability of capital | -965,8 | 117 | 35,8 | -81,2 |
Equity capital to total assets | 6,7 | -87,5 | -157 | -69,5 |
Gross profit margin | -120,5 | -22,4 | -12,5 | 9,9 |
EBITDA Margin | -113,6 | -19,3 | -6,9 | 12,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 166 | 150 | 183 | 33 |
Current financial liquidity indicator | 3.902988910675049 | 0.4962667226791382 | 0.24983780086040497 | -0,3 |
Net dept to EBITDA | 0.39702102541923523 | -0.8473615646362305 | -5.851482391357422 | -5,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane